Soros Fund Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,295
Closed -$1.96M 247
2025
Q3
$1.96M Buy
+4,295
New +$1.75M 0.03% 167
2025
Q2
Sell
-60,000
Closed -$16.2M 210
2025
Q1
$16.2M Buy
+60,000
New +$15.4M 0.29% 106
2019
Q3
Sell
-40,000
Closed -$2.9M 176
2019
Q2
$2.9M Buy
+40,000
New +$3.07M 0.07% 116
2017
Q3
Sell
-7,000
Closed -$558K 231
2017
Q2
$558K Buy
+7,000
New +$447K 0.02% 125
2016
Q1
Sell
-6,000
Closed -$565K 233
2015
Q4
$565K Buy
+6,000
New +$556K 0.01% 180
2014
Q2
Sell
-3,092
Closed -$208K 366
2014
Q1
$208K Buy
+3,092
New +$239K ﹤0.01% 302

Other funds holding ALNY